Status:
COMPLETED
Cardioprotective Effect of Ketamine-dexmeditomidine Versus Fentanyl-midazolam in Open Heart Surgery in Pediatrics
Lead Sponsor:
Cairo University
Conditions:
Anesthesia
Eligibility:
All Genders
6-24 years
Phase:
PHASE1
Brief Summary
congenital hearts are very sensitive and irritable to deal with, especially during repair defects, the child's heart is exposed to impaired myocardial function during the entire procedure. Moreover, r...
Detailed Description
Myocardial protection is an important issue. This is reflected in the clinical prognosis of patients undergoing cardiac surgery and this can be measured by the most popular Cardiac biomarkers ( cardia...
Eligibility Criteria
Inclusion
- the American Society of Anesthesiologists II and III
- elective open Congenital cardiac surgery(VSD, AV canal, and partial anomaly) using cardiopulmonary bypass
Exclusion
- less than 6 months or more than 24 months.
- weight \< 5 kg.
- cyanotic heart disease
- patients with heart failure, an implantable pacemaker, pulmonary hypertension, preoperative administration of inotropic agents, serum creatinine higher than1.5 mg/dL, chronic liver disease, patients receiving sulfonylurea, theophylline, or allopurinol
Key Trial Info
Start Date :
April 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 25 2022
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT05314569
Start Date
April 15 2022
End Date
September 25 2022
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amany Hassan Saleh
Giza, Egypt, 02